This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siddiqui, A. A.
Right arrow Articles by Pompa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siddiqui, A. A.
Right arrow Articles by Pompa, J.

 Previous Article  |  Next Article 

Infection and Immunity, July 2003, p. 3844-3851, Vol. 71, No. 7
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.7.3844-3851.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Induction of Protective Immunity against Schistosoma mansoni via DNA Priming and Boosting with the Large Subunit of Calpain (Sm-p80): Adjuvant Effects of Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-4

Afzal A. Siddiqui,1,2* Troy Phillips,1 Hugues Charest,3 Ron B. Podesta,4 Martha L. Quinlin,1 Justin R. Pinkston,1 Jenny D. Lloyd,1 Michelle Paz,1 Rachael M. Villalovos,1 and Janet Pompa1

Department of Internal Medicine, Texas Tech University Health Sciences Center,1 Veterans Affairs Health Care System, Amarillo, Texas 79106,2 Laboratoire de Santé Publique du Québec, Programme de Biologie Moléculaire, Ste-Anne-de-Bellevue, Québec,3 Department of Zoology, University of Western Ontario, London, Canada4

Received 10 February 2003/ Returned for modification 21 April 2003/ Accepted 23 April 2003

Considerable morbidity and mortality result from schistosomiasis, an affliction affecting an estimated 200 million people. Although schistosomicidal drugs and other control measures (including public hygiene and snail control) exist, the advent of an efficacious vaccine remains the most potentially powerful means for controlling this disease. We have targeted a vaccine candidate (large subunit of calpain, Sm-p80) because of its consistent immunogenicity, protective potential, and integral role in surface membrane biogenesis of schistosomes. Since surface membrane renewal appears to be one of the major phenomena employed by schistosomes to evade the host's immune system; an immune response directed against Sm-p80 should render the parasite susceptible to immune clearance from the host by both providing a focus of attack and by potentially impairing the membrane repair process. In the present study, we have employed DNA immunization protocols using Sm-p80 with plasmids encoding granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4). Sm-p80 by itself provided 39% protection (P = ≤0.0001) against challenge infection in C57BL/6 mice. This protection was increased to 44% (P = ≤0.0001) when the plasmid encoding GM-CSF was coadministered with Sm-p80 DNA. Coinjection of plasmid DNA encoding IL-4 with Sm-p80 DNA yielded a protection level of 42% (P = ≤0.0001). Statistically, the protection conferred by including GM-CSF, but not IL-4, was significantly greater than that when only Sm-p80 was used. Sm-p80 DNA by itself elicited strong responses that include IgG2A and IgG2B antibody isotypes. The introduction of GM-CSF DNA with Sm-p80 DNA led to distinct increases in total IgG and IgG1 titers, whereas the coadministration of IL-4 DNA with Sm-p80 DNA resulted in a slight elevation of IgG1 and IgG3 titers and in some reduction of IgG2A and IgG2B titers. Our data again indicate that Sm-p80 can be an excellent candidate for a schistosomiasis vaccine.

* Corresponding author. Mailing address: Texas Tech Women's Health & Research Institute, 1400 Wallace Blvd., Amarillo, TX 79106-1791. Phone: (806) 354-5524. Fax: (806) 354-5791. E-mail: siddiqui{at}ama.ttuhsc.edu.

Editor: W. A. Petri, Jr.

Infection and Immunity, July 2003, p. 3844-3851, Vol. 71, No. 7
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.7.3844-3851.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ryan, A. A., Wozniak, T. M., Shklovskaya, E., O'Donnell, M. A., Fazekas de St. Groth, B., Britton, W. J., Triccas, J. A. (2007). Improved Protection against Disseminated Tuberculosis by Mycobacterium bovis Bacillus Calmette-Guerin Secreting Murine GM-CSF Is Associated with Expansion and Activation of APCs. J. Immunol. 179: 8418-8424 [Abstract] [Full Text]  
  • Kerepesi, L. A., Keiser, P. B., Nolan, T. J., Schad, G. A., Abraham, D., Nutman, T. B. (2005). DNA Immunization with Na+-K+ATPase (Sseat-6) Induces Protective Immunity to Larval Strongyloides stercoralis in Mice. Infect. Immun. 73: 2298-2305 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»